3rd Circ. Panel Questions Niaspan Buyers' Class Data

By Matthew Perlman · September 6, 2022, 7:52 PM EDT

A Third Circuit panel on Tuesday raised a number of questions for Niaspan buyers about the data supporting their bid for class status in a case accusing AbbVie and Teva Pharmaceuticals...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In Re: Niaspan Antitrust Litigation

Case Number

21-2895

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

October 14, 2021